January 22, 2026 12:33 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Twist before Tamil Nadu polls! TTV Dhinakaran returns to NDA after bitter exit | Gold goes berserk! Prices smash all-time high as global tensions explode | Markets end in red: Sensex slips 271 points, Nifty below 25,200; rupee hits record low | Nitin Nabin becomes BJP’s youngest president ahead of key assembly polls, PM Modi calls him ‘my boss’ | Viral video scandal rocks Karnataka Police: DGP Ramachandra Rao suspended | Jolt to ECI over SIR! SC allows BLAs at hearing, questions 'logical discrepancy'; TMC declares 'BJP's game over' | Will dal disrupt diplomacy? US lawmakers urge Trump to act on India’s 30% pulse tariff | 'Pakistan deserves Operation Sindoor 2.0', says Baloch leader over Trump’s Gaza board invitation to Islamabad | From Malda to the nation: PM Modi unveils India’s Vande Bharat sleeper | War zone Beldanga: Highway blocked, reporters attacked in migrant death protests
Imran Khan

Pakistani Prime Minister Imran Khan oks COVID-19 vaccine procurement from 2 firms - Reports

| @indiablooms | Nov 17, 2020, at 11:10 pm

Moscow/Sputnik: Pakistani Prime Minister Imran Khan has greenlighted advance booking of COVID-19 vaccines with two unnamed candidates in the running, media reported Tuesday.

According to news outlet Geo Pakistan, Parliamentary Secretary for Health Nausheen Hamid said that 10 million Pakistani nationals will be vaccinated during the first phase, with the priority given to frontline workers and people aged over 65 years.

No details of the origin of the shortlisted vaccines were given, although Pakistan’s coronavirus taskforce last week indicated that authorities will consider Chinese-made vaccines over US-made ones due to the different requirements in transportation and storage, Geo Pakistan reported.

The vaccines produced by US firms Pfizer and Moderna must be stored in temperatures of -30 to -90 degrees Fahrenheit, requiring what is called a cold chain, a major challenge for vaccine distribution in developing nations.

Chinese-made vaccines, which are currently undergoing third phase trials in Pakistan, remain effective at room temperatures, Geo reported citing the taskforce.

Fewer than a dozen vaccine candidates are showing efficacy in the third phase trials, mainly from the US, Russia and China, while many other COVID-19 vaccine developments are still underway. Many nations have begun scrambling to secure pledges of vaccine procurement before they are mass-produced.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.